#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14386	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2015	706.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1428	1428	C	899	C	857	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14386	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2015	706.9	0	HET	.	.	.	C207T	.	207	207	C	451	451	C	812	C,T	593,169	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	14386	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2015	706.9	0	HET	.	.	.	C451T,A	.	451	451	C	695	695	C	827	C,T,A	394,372,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26464	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3678	717.6	0	.	n	.	0	T695C	SNP	695	695	T	1029	1029	C	847	C,T	811,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26464	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3678	717.6	0	.	n	.	0	A1638G	SNP	1638	1638	A	1972	1972	G	836	G,A	590,196	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26464	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3678	717.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2305	2305	C	841	C	781	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26464	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3678	717.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2379	2379	A	831	A	787	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26464	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3678	717.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2931	2931	C	781	C	746	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26464	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3678	717.6	0	HET	.	.	.	C1811T	.	1811	1811	C	2145	2145	C	820	C,T	573,202	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26464	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3678	717.6	0	HET	.	.	.	A704G	.	704	704	A	1038	1038	A	823	A,G	595,186	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1920	folP	855	855	100.0	folP.l15.c4.ctg.1	1573	121.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1000	1002	AGC	224;220;217	A;G,A;C	209;205,1;203	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5588	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3448	161.7	1	SNP	p	S91F	1	.	.	271	273	TTC	628	630	TTC	224;224;229	T;T;C	206;206;210	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5588	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3448	161.7	1	SNP	p	D95G	1	.	.	283	285	GGC	640	642	GGC	215;218;219	G;G,A;C,G	205;205,1;205,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5588	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3448	161.7	1	SNP	p	G95N	0	.	.	283	285	GGC	640	642	GGC	215;218;219	G;G,A;C,G	205;205,1;205,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1604	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1405	113.8	1	SNP	p	G45D	0	.	.	133	135	GGC	493	495	GGC	193;193;195	G;G;C	183;182;179	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	878	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1045	83.1	0	.	n	.	0	A197.	DEL	197	197	A	561	561	A	196	A	184	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4964	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3048	162.3	1	SNP	p	D86N	0	.	.	256	258	GAC	570	572	GAC	201;200;200	G;A;C	186;185;189	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4964	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3048	162.3	1	SNP	p	R87W	0	.	.	259	261	CGT	573	575	CGT	201;200;203	C,T;G;T	191,1;193;191	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4964	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3048	162.3	1	SNP	p	S87R	1	.	.	259	261	CGT	573	575	CGT	201;200;203	C,T;G;T	191,1;193;191	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4964	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3048	162.3	1	SNP	p	R87I	0	.	.	259	261	CGT	573	575	CGT	201;200;203	C,T;G;T	191,1;193;191	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4964	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3048	162.3	1	SNP	p	S88P	0	.	.	262	264	TCC	576	578	TCC	207;208;210	T;C;C	195;199;200	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4266	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2726	155.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1497	1499	GGC	218;217;216	G;G;C,T	200;197;197,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2342	162.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1192	1194	GCC	203;203;204	G;C;C	192;194;195	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2342	162.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1195	1197	ATG	205;205;201	A;T;G	195;194;190	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2342	162.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1207	1209	ACC	189;187;187	A;C,A;C	178;178,1;178	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2342	162.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1207	1209	ACC	189;187;187	A;C,A;C	178;178,1;178	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2342	162.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1708	1710	ACC	207;206;208	A;C;C	189;191;192	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2342	162.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1762	1764	GCG	195;194;188	G,T;C;G	184,1;185;179	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2342	162.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1762	1764	GCG	195;194;188	G,T;C;G	184,1;185;179	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2342	162.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1885	1887	GGT	176;173;174	G;G;T	166;162;161	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2342	162.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1894	1896	AGC	162;160;161	A;G;C	153;152;152	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3830	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2342	162.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1912	1914	CCG	132;140;138	C,G;C,G;G	95,4;107,1;101	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5502	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3103	176.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1633	1635	CCG	197;196;195	C;C;G	179;185;178	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2354	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1861	125.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	547	547	C	156	C	145	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2768	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1747	157.7	1	SNP	p	G120K	1	.	.	358	360	AAG	659	661	AAG	233;233;233	A;A;G	218;222;218	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2768	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1747	157.7	1	SNP	p	A121N	1	.	.	361	363	AAC	662	664	AAC	231;229;225	A;A;C	213;218;211	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2768	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1747	157.7	1	SNP	p	N121D	0	.	.	361	363	AAC	662	664	AAC	231;229;225	A;A;C	213;218;211	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9902	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	5021	196.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1018	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1057	95.6	1	SNP	p	V57M	1	.	.	169	171	ATG	526	528	ATG	208;209;207	A;T;G	201;201;199	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
